Appointments to The Code of Practice Appeal Board
The Prescription Medicines Code of Practice Authority (PMCPA) is responsible for administering the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry at arm’s length from the ABPI itself. In particular, the PMCPA adjudicates upon complaints about pharmaceutical companies made under the Code. The ABPI represents research–based biopharmaceutical companies supplying medicines to the NHS.
The aim of the Code is to ensure that the promotion of prescription medicines is carried out in a responsible, ethical and professional manner to support high quality patient care. The Code also covers the provision of information to the public about prescription only medicines and relationships with patient organisations.
The main roles of the Code of Practice Appeal Board are to hear appeals against the decisions made by the Code of Practice Panel and to supervise the activities of the Panel. The Appeal Board Chairman is independent and legally qualified. In addition there are eight independent members and eight members from pharmaceutical companies. Independent members, including the Chairman, must be in a majority when appeals are heard.
As a result of one of the independent members completing their term of service we are seeking to appoint one member from an independent body involved with providing information on medicines in 2016.
The appointment will be made by the ABPI Board of Management following consultation with the Medicines and Healthcare products Regulatory Agency.
Meetings of the Appeal Board are held approximately every 4 - 5 weeks in central London. Members are expected to make every effort to attend the meetings, read the papers in detail beforehand and contribute to meetings. They receive an annual honorarium plus a meeting attendance fee and associated expenses. Additional time will be required for training.
Information about the ABPI Code, the PMCPA and this appointment, and an application form, are available in the right hand links.
Applications have now closed.